Leukaemia results from a malignant proliferation of cells in the bone marrow. The prognosis is defined by the disease's biological characteristics. Treatment is based on chemotherapy. In cases of high-risk leukaemia, an allograft may be proposed. The arrival of targeted therapies and immunotherapy has revolutionised the prognosis of the disease. The challenge of the next few years will be to define the place of these therapies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.revinf.2019.09.002 | DOI Listing |
Publication Analysis
Top Keywords
high-risk leukaemia
8
leukaemia allograft
8
[treatment high-risk
4
allograft immunotherapy]
4
immunotherapy] leukaemia
4
leukaemia malignant
4
malignant proliferation
4
proliferation cells
4
cells bone
4
bone marrow
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!